The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CD160 Protein Market Research Report 2025
Synopsis
CD160 Protein is a cell membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain.
The global CD160 Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CD160 Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CD160 Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CD160 Protein in SDS-PAGE is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CD160 Protein include Sino Biological, Inc., Bio-Techne, Abcam, Elabscience Biotechnology Inc., ZellBio GmbH, GeneTex, LifeSpan BioSciences, Inc, Biorbyt and Prospec-Tany Technogene Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD160 Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD160 Protein.
Report Scope
The CD160 Protein market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CD160 Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD160 Protein companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sino Biological, Inc.
Bio-Techne
Abcam
Elabscience Biotechnology Inc.
ZellBio GmbH
GeneTex
LifeSpan BioSciences, Inc
Biorbyt
Prospec-Tany Technogene Ltd.
Abbexa
ProSci Incorporated
CUSABIO
Thermo Fisher
KACTUS
Creative Biolabs
BioLegend
Segment by Type
Purity:Greater Than 90%
Purity:Greater Than 95%
Purity:Greater Than 98%
Others
Segment by Application
SDS-PAGE
ELISA
Western Blot
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD160 Protein companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CD160 Protein is a cell membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain.
The global CD160 Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CD160 Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CD160 Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CD160 Protein in SDS-PAGE is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CD160 Protein include Sino Biological, Inc., Bio-Techne, Abcam, Elabscience Biotechnology Inc., ZellBio GmbH, GeneTex, LifeSpan BioSciences, Inc, Biorbyt and Prospec-Tany Technogene Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD160 Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD160 Protein.
Report Scope
The CD160 Protein market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CD160 Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD160 Protein companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sino Biological, Inc.
Bio-Techne
Abcam
Elabscience Biotechnology Inc.
ZellBio GmbH
GeneTex
LifeSpan BioSciences, Inc
Biorbyt
Prospec-Tany Technogene Ltd.
Abbexa
ProSci Incorporated
CUSABIO
Thermo Fisher
KACTUS
Creative Biolabs
BioLegend
Segment by Type
Purity:Greater Than 90%
Purity:Greater Than 95%
Purity:Greater Than 98%
Others
Segment by Application
SDS-PAGE
ELISA
Western Blot
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD160 Protein companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD160 Protein Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Purity:Greater Than 90%
1.2.3 Purity:Greater Than 95%
1.2.4 Purity:Greater Than 98%
1.2.5 Others
1.3 Market by Application
1.3.1 Global CD160 Protein Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SDS-PAGE
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunofluorescence
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD160 Protein Market Perspective (2019-2030)
2.2 CD160 Protein Growth Trends by Region
2.2.1 Global CD160 Protein Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CD160 Protein Historic Market Size by Region (2019-2024)
2.2.3 CD160 Protein Forecasted Market Size by Region (2025-2030)
2.3 CD160 Protein Market Dynamics
2.3.1 CD160 Protein Industry Trends
2.3.2 CD160 Protein Market Drivers
2.3.3 CD160 Protein Market Challenges
2.3.4 CD160 Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD160 Protein Players by Revenue
3.1.1 Global Top CD160 Protein Players by Revenue (2019-2024)
3.1.2 Global CD160 Protein Revenue Market Share by Players (2019-2024)
3.2 Global CD160 Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CD160 Protein Revenue
3.4 Global CD160 Protein Market Concentration Ratio
3.4.1 Global CD160 Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD160 Protein Revenue in 2023
3.5 CD160 Protein Key Players Head office and Area Served
3.6 Key Players CD160 Protein Product Solution and Service
3.7 Date of Enter into CD160 Protein Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CD160 Protein Breakdown Data by Type
4.1 Global CD160 Protein Historic Market Size by Type (2019-2024)
4.2 Global CD160 Protein Forecasted Market Size by Type (2025-2030)
5 CD160 Protein Breakdown Data by Application
5.1 Global CD160 Protein Historic Market Size by Application (2019-2024)
5.2 Global CD160 Protein Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CD160 Protein Market Size (2019-2030)
6.2 North America CD160 Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CD160 Protein Market Size by Country (2019-2024)
6.4 North America CD160 Protein Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD160 Protein Market Size (2019-2030)
7.2 Europe CD160 Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CD160 Protein Market Size by Country (2019-2024)
7.4 Europe CD160 Protein Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD160 Protein Market Size (2019-2030)
8.2 Asia-Pacific CD160 Protein Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CD160 Protein Market Size by Region (2019-2024)
8.4 Asia-Pacific CD160 Protein Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD160 Protein Market Size (2019-2030)
9.2 Latin America CD160 Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CD160 Protein Market Size by Country (2019-2024)
9.4 Latin America CD160 Protein Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD160 Protein Market Size (2019-2030)
10.2 Middle East & Africa CD160 Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CD160 Protein Market Size by Country (2019-2024)
10.4 Middle East & Africa CD160 Protein Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Detail
11.1.2 Sino Biological, Inc. Business Overview
11.1.3 Sino Biological, Inc. CD160 Protein Introduction
11.1.4 Sino Biological, Inc. Revenue in CD160 Protein Business (2019-2024)
11.1.5 Sino Biological, Inc. Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Detail
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne CD160 Protein Introduction
11.2.4 Bio-Techne Revenue in CD160 Protein Business (2019-2024)
11.2.5 Bio-Techne Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam CD160 Protein Introduction
11.3.4 Abcam Revenue in CD160 Protein Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Elabscience Biotechnology Inc.
11.4.1 Elabscience Biotechnology Inc. Company Detail
11.4.2 Elabscience Biotechnology Inc. Business Overview
11.4.3 Elabscience Biotechnology Inc. CD160 Protein Introduction
11.4.4 Elabscience Biotechnology Inc. Revenue in CD160 Protein Business (2019-2024)
11.4.5 Elabscience Biotechnology Inc. Recent Development
11.5 ZellBio GmbH
11.5.1 ZellBio GmbH Company Detail
11.5.2 ZellBio GmbH Business Overview
11.5.3 ZellBio GmbH CD160 Protein Introduction
11.5.4 ZellBio GmbH Revenue in CD160 Protein Business (2019-2024)
11.5.5 ZellBio GmbH Recent Development
11.6 GeneTex
11.6.1 GeneTex Company Detail
11.6.2 GeneTex Business Overview
11.6.3 GeneTex CD160 Protein Introduction
11.6.4 GeneTex Revenue in CD160 Protein Business (2019-2024)
11.6.5 GeneTex Recent Development
11.7 LifeSpan BioSciences, Inc
11.7.1 LifeSpan BioSciences, Inc Company Detail
11.7.2 LifeSpan BioSciences, Inc Business Overview
11.7.3 LifeSpan BioSciences, Inc CD160 Protein Introduction
11.7.4 LifeSpan BioSciences, Inc Revenue in CD160 Protein Business (2019-2024)
11.7.5 LifeSpan BioSciences, Inc Recent Development
11.8 Biorbyt
11.8.1 Biorbyt Company Detail
11.8.2 Biorbyt Business Overview
11.8.3 Biorbyt CD160 Protein Introduction
11.8.4 Biorbyt Revenue in CD160 Protein Business (2019-2024)
11.8.5 Biorbyt Recent Development
11.9 Prospec-Tany Technogene Ltd.
11.9.1 Prospec-Tany Technogene Ltd. Company Detail
11.9.2 Prospec-Tany Technogene Ltd. Business Overview
11.9.3 Prospec-Tany Technogene Ltd. CD160 Protein Introduction
11.9.4 Prospec-Tany Technogene Ltd. Revenue in CD160 Protein Business (2019-2024)
11.9.5 Prospec-Tany Technogene Ltd. Recent Development
11.10 Abbexa
11.10.1 Abbexa Company Detail
11.10.2 Abbexa Business Overview
11.10.3 Abbexa CD160 Protein Introduction
11.10.4 Abbexa Revenue in CD160 Protein Business (2019-2024)
11.10.5 Abbexa Recent Development
11.11 ProSci Incorporated
11.11.1 ProSci Incorporated Company Detail
11.11.2 ProSci Incorporated Business Overview
11.11.3 ProSci Incorporated CD160 Protein Introduction
11.11.4 ProSci Incorporated Revenue in CD160 Protein Business (2019-2024)
11.11.5 ProSci Incorporated Recent Development
11.12 CUSABIO
11.12.1 CUSABIO Company Detail
11.12.2 CUSABIO Business Overview
11.12.3 CUSABIO CD160 Protein Introduction
11.12.4 CUSABIO Revenue in CD160 Protein Business (2019-2024)
11.12.5 CUSABIO Recent Development
11.13 Thermo Fisher
11.13.1 Thermo Fisher Company Detail
11.13.2 Thermo Fisher Business Overview
11.13.3 Thermo Fisher CD160 Protein Introduction
11.13.4 Thermo Fisher Revenue in CD160 Protein Business (2019-2024)
11.13.5 Thermo Fisher Recent Development
11.14 KACTUS
11.14.1 KACTUS Company Detail
11.14.2 KACTUS Business Overview
11.14.3 KACTUS CD160 Protein Introduction
11.14.4 KACTUS Revenue in CD160 Protein Business (2019-2024)
11.14.5 KACTUS Recent Development
11.15 Creative Biolabs
11.15.1 Creative Biolabs Company Detail
11.15.2 Creative Biolabs Business Overview
11.15.3 Creative Biolabs CD160 Protein Introduction
11.15.4 Creative Biolabs Revenue in CD160 Protein Business (2019-2024)
11.15.5 Creative Biolabs Recent Development
11.16 BioLegend
11.16.1 BioLegend Company Detail
11.16.2 BioLegend Business Overview
11.16.3 BioLegend CD160 Protein Introduction
11.16.4 BioLegend Revenue in CD160 Protein Business (2019-2024)
11.16.5 BioLegend Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global CD160 Protein Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Purity:Greater Than 90%
Table 3. Key Players of Purity:Greater Than 95%
Table 4. Key Players of Purity:Greater Than 98%
Table 5. Key Players of Others
Table 6. Global CD160 Protein Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global CD160 Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global CD160 Protein Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global CD160 Protein Market Share by Region (2019-2024)
Table 10. Global CD160 Protein Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global CD160 Protein Market Share by Region (2025-2030)
Table 12. CD160 Protein Market Trends
Table 13. CD160 Protein Market Drivers
Table 14. CD160 Protein Market Challenges
Table 15. CD160 Protein Market Restraints
Table 16. Global CD160 Protein Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global CD160 Protein Market Share by Players (2019-2024)
Table 18. Global Top CD160 Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD160 Protein as of 2023)
Table 19. Ranking of Global Top CD160 Protein Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by CD160 Protein Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players CD160 Protein Product Solution and Service
Table 23. Date of Enter into CD160 Protein Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CD160 Protein Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global CD160 Protein Revenue Market Share by Type (2019-2024)
Table 27. Global CD160 Protein Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global CD160 Protein Revenue Market Share by Type (2025-2030)
Table 29. Global CD160 Protein Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global CD160 Protein Revenue Market Share by Application (2019-2024)
Table 31. Global CD160 Protein Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global CD160 Protein Revenue Market Share by Application (2025-2030)
Table 33. North America CD160 Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America CD160 Protein Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America CD160 Protein Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe CD160 Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe CD160 Protein Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe CD160 Protein Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific CD160 Protein Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific CD160 Protein Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific CD160 Protein Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America CD160 Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America CD160 Protein Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America CD160 Protein Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa CD160 Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa CD160 Protein Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa CD160 Protein Market Size by Country (2025-2030) & (US$ Million)
Table 48. Sino Biological, Inc. Company Detail
Table 49. Sino Biological, Inc. Business Overview
Table 50. Sino Biological, Inc. CD160 Protein Product
Table 51. Sino Biological, Inc. Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 52. Sino Biological, Inc. Recent Development
Table 53. Bio-Techne Company Detail
Table 54. Bio-Techne Business Overview
Table 55. Bio-Techne CD160 Protein Product
Table 56. Bio-Techne Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 57. Bio-Techne Recent Development
Table 58. Abcam Company Detail
Table 59. Abcam Business Overview
Table 60. Abcam CD160 Protein Product
Table 61. Abcam Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 62. Abcam Recent Development
Table 63. Elabscience Biotechnology Inc. Company Detail
Table 64. Elabscience Biotechnology Inc. Business Overview
Table 65. Elabscience Biotechnology Inc. CD160 Protein Product
Table 66. Elabscience Biotechnology Inc. Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 67. Elabscience Biotechnology Inc. Recent Development
Table 68. ZellBio GmbH Company Detail
Table 69. ZellBio GmbH Business Overview
Table 70. ZellBio GmbH CD160 Protein Product
Table 71. ZellBio GmbH Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 72. ZellBio GmbH Recent Development
Table 73. GeneTex Company Detail
Table 74. GeneTex Business Overview
Table 75. GeneTex CD160 Protein Product
Table 76. GeneTex Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 77. GeneTex Recent Development
Table 78. LifeSpan BioSciences, Inc Company Detail
Table 79. LifeSpan BioSciences, Inc Business Overview
Table 80. LifeSpan BioSciences, Inc CD160 Protein Product
Table 81. LifeSpan BioSciences, Inc Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 82. LifeSpan BioSciences, Inc Recent Development
Table 83. Biorbyt Company Detail
Table 84. Biorbyt Business Overview
Table 85. Biorbyt CD160 Protein Product
Table 86. Biorbyt Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 87. Biorbyt Recent Development
Table 88. Prospec-Tany Technogene Ltd. Company Detail
Table 89. Prospec-Tany Technogene Ltd. Business Overview
Table 90. Prospec-Tany Technogene Ltd. CD160 Protein Product
Table 91. Prospec-Tany Technogene Ltd. Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 92. Prospec-Tany Technogene Ltd. Recent Development
Table 93. Abbexa Company Detail
Table 94. Abbexa Business Overview
Table 95. Abbexa CD160 Protein Product
Table 96. Abbexa Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 97. Abbexa Recent Development
Table 98. ProSci Incorporated Company Detail
Table 99. ProSci Incorporated Business Overview
Table 100. ProSci Incorporated CD160 Protein Product
Table 101. ProSci Incorporated Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 102. ProSci Incorporated Recent Development
Table 103. CUSABIO Company Detail
Table 104. CUSABIO Business Overview
Table 105. CUSABIO CD160 Protein Product
Table 106. CUSABIO Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 107. CUSABIO Recent Development
Table 108. Thermo Fisher Company Detail
Table 109. Thermo Fisher Business Overview
Table 110. Thermo Fisher CD160 Protein Product
Table 111. Thermo Fisher Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 112. Thermo Fisher Recent Development
Table 113. KACTUS Company Detail
Table 114. KACTUS Business Overview
Table 115. KACTUS CD160 Protein Product
Table 116. KACTUS Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 117. KACTUS Recent Development
Table 118. Creative Biolabs Company Detail
Table 119. Creative Biolabs Business Overview
Table 120. Creative Biolabs CD160 Protein Product
Table 121. Creative Biolabs Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 122. Creative Biolabs Recent Development
Table 123. BioLegend Company Detail
Table 124. BioLegend Business Overview
Table 125. BioLegend CD160 Protein Product
Table 126. BioLegend Revenue in CD160 Protein Business (2019-2024) & (US$ Million)
Table 127. BioLegend Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD160 Protein Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CD160 Protein Market Share by Type: 2023 VS 2030
Figure 3. Purity:Greater Than 90% Features
Figure 4. Purity:Greater Than 95% Features
Figure 5. Purity:Greater Than 98% Features
Figure 6. Others Features
Figure 7. Global CD160 Protein Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global CD160 Protein Market Share by Application: 2023 VS 2030
Figure 9. SDS-PAGE Case Studies
Figure 10. ELISA Case Studies
Figure 11. Western Blot Case Studies
Figure 12. Immunofluorescence Case Studies
Figure 13. Others Case Studies
Figure 14. CD160 Protein Report Years Considered
Figure 15. Global CD160 Protein Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global CD160 Protein Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global CD160 Protein Market Share by Region: 2023 VS 2030
Figure 18. Global CD160 Protein Market Share by Players in 2023
Figure 19. Global Top CD160 Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD160 Protein as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by CD160 Protein Revenue in 2023
Figure 21. North America CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America CD160 Protein Market Share by Country (2019-2030)
Figure 23. United States CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe CD160 Protein Market Share by Country (2019-2030)
Figure 27. Germany CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific CD160 Protein Market Share by Region (2019-2030)
Figure 35. China CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America CD160 Protein Market Share by Country (2019-2030)
Figure 43. Mexico CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa CD160 Protein Market Share by Country (2019-2030)
Figure 47. Turkey CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia CD160 Protein Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Sino Biological, Inc. Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 50. Bio-Techne Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 51. Abcam Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 52. Elabscience Biotechnology Inc. Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 53. ZellBio GmbH Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 54. GeneTex Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 55. LifeSpan BioSciences, Inc Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 56. Biorbyt Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 57. Prospec-Tany Technogene Ltd. Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 58. Abbexa Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 59. ProSci Incorporated Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 60. CUSABIO Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 61. Thermo Fisher Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 62. KACTUS Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 63. Creative Biolabs Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 64. BioLegend Revenue Growth Rate in CD160 Protein Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
